Alzamend Neuro, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Alzamend Neuro, Inc. (ALZN), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ALZN insiders buying or selling?
In the last 12 months, Alzamend Neuro, Inc. insiders reported 3 open-market purchases ($330.8K) and 4 sales ($14.1K) — net buying of $316.8K. Since June 2021, Trabud has recorded 96 Form 4 filings for ALZN: 79 buys ($19.2M) and 17 sells ($2.0M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $111.0K by AULT MILTON C III (Director) on Aug 31, 2026. SEC ↗
- The most recent open-market purchase was reported on Aug 31, 2026 (49 days ago).
Key Statistics (June 2021 – Aug 31, 2026)
Total Form 4 filings
96
SEC EDGAR
Insider filers
6
Insider buys (79)
$19.2M
Insider sells (17)
$2.0M
Insider sentiment
Net buyingNet insider flow of $17.2M in net buying since June 2021, and $316.8K in net buying over the last 12 months. 2 insider buys in the last 90 days.
Recent ALZN insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | AULT MILTON C III | Director | Sale | 2.0K | $1.56 | $3.1K | SEC ↗ |
| Aug 31, 2026 | AULT MILTON C III | Director | Purchase | 110.4K | $1.01 | $111.0K | SEC ↗ |
| Aug 31, 2026 | AULT MILTON C III | Director | Purchase | 110.4K | $1.01 | $111.0K | SEC ↗ |
| Apr 16, 2026 | AULT MILTON C III | Director | Purchase | 108.4K | $1.00 | $108.9K | SEC ↗ |
| Dec 30, 2025 | AULT MILTON C III | Director | Sale | 1.9K | $2.07 | $3.8K | SEC ↗ |
| Dec 23, 2025 | William B. Horne | Director | Sale | 3.3K | $2.12 | $7.1K | SEC ↗ |
| Oct 24, 2025 | Lynne Fahey Mcgrath | Director | Sale | 30 | $2.29 | $68.7 | SEC ↗ |
| Oct 10, 2025 | AULT MILTON C III | Director | Sale | 121.8K | $2.42 | $294.5K | SEC ↗ |
| Oct 8, 2025 | AULT MILTON C III | Director | Sale | 139.4K | $2.47 | $344.2K | SEC ↗ |
| Oct 4, 2025 | AULT MILTON C III | Director | Sale | 123.4K | $2.41 | $296.8K | SEC ↗ |
| Sep 30, 2025 | AULT MILTON C III | Director, 10% Owner | Sale | 79.6K | $2.31 | $184.2K | SEC ↗ |
| Sep 26, 2025 | AULT MILTON C III | Director, 10% Owner | Sale | 97.0K | $2.34 | $226.9K | SEC ↗ |
| Sep 23, 2025 | AULT MILTON C III | Director, 10% Owner | Sale | 77.0K | $2.35 | $180.9K | SEC ↗ |
| Sep 19, 2025 | AULT MILTON C III | Director, 10% Owner | Sale | 23.0K | $2.47 | $56.7K | SEC ↗ |
| Jul 29, 2025 | AULT MILTON C III | Director, 10% Owner | Sale | 44.8K | $2.86 | $128.2K | SEC ↗ |
| Jul 26, 2025 | AULT MILTON C III | Director, 10% Owner | Sale | 69.1K | $2.95 | $203.8K | SEC ↗ |
| May 14, 2025 | AULT MILTON C III | Director, 10% Owner | Sale | 1.2K | $5.06 | $6.2K | SEC ↗ |
| Mar 27, 2025 | William B. Horne | Director | Purchase | 3.3K | $0.99 | $3.3K | SEC ↗ |
| Mar 25, 2025 | AULT MILTON C III | Director, 10% Owner | Purchase | 2.9K | $1.02 | $3.0K | SEC ↗ |
| Mar 24, 2025 | David J Katzoff | Chief Financial Officer | Purchase | 5.0K | $1.01 | $5.0K | SEC ↗ |
| Mar 20, 2025 | William B. Horne | Director | Purchase | 5.0K | $0.98 | $4.9K | SEC ↗ |
| Mar 19, 2025 | William B. Horne | Director | Purchase | 5.0K | $0.97 | $4.9K | SEC ↗ |
| Mar 18, 2025 | AULT MILTON C III | Director, 10% Owner | Purchase | 5.0K | $0.96 | $4.8K | SEC ↗ |
| Mar 14, 2025 | AULT MILTON C III | Director, 10% Owner | Purchase | 100 | $0.68 | $68.42 | SEC ↗ |
| Aug 14, 2024 | AULT MILTON C III | Director, 10% Owner | Purchase | 75 | $2.75 | $206.25 | SEC ↗ |
Showing the 25 most recent of 96 Form 4 filings for Alzamend Neuro, Inc..
Most active ALZN insiders
- AULT MILTON C III83 filings
- William B. Horne4 filings
- David J Katzoff3 filings
- GUSTAFSON MARK2 filings
- Lynne Fahey Mcgrath2 filings
Ask anything about ALZN insider activity
Use Trabud's AI agent to query Alzamend Neuro, Inc.'s Form 4 history in plain English — "Show me ALZN CEO purchases this year" or compare it against any other ticker.
Open the AI agentALZN insider trading FAQ
Are Alzamend Neuro, Inc. insiders buying or selling?
In the last 12 months, Alzamend Neuro, Inc. insiders reported 3 open-market purchases ($330.8K) and 4 sales ($14.1K) — net buying of $316.8K. Since June 2021, Trabud has recorded 96 Form 4 filings for ALZN: 79 buys ($19.2M) and 17 sells ($2.0M). Over the full record that is net buying of $17.2M.
How many insiders trade ALZN stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Alzamend Neuro, Inc.. The most recent filing was accepted on Aug 31, 2026.
Where does Trabud get ALZN insider trading data?
All ALZN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.